Pulse Steroid Injection in Refractory Rheumatoid Arthritis
Revealing the Potential of Intravenous Pulse Steroid Therapy; Impressive Results in Attaining Remission or Low Disease Activity in Refractory Rheumatoid Arthritis
Sohag University
268 participants
May 1, 2024
INTERVENTIONAL
Conditions
Summary
Remission or low disease activity in active rheumatoid arthritis
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
125 mg methylprednisolone intravenous pulse on 2 consecutive days
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06456489